| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Total Income - EUR | 0 | 0 | 0 | 322 | 0 | 0 | 0 | - | - | - |
| Total Expenses - EUR | 207 | 172 | 169 | 195 | 162 | 159 | 13 | - | - | - |
| Gross Profit/Loss - EUR | -207 | -172 | -169 | 127 | -162 | -159 | -13 | - | - | - |
| Net Profit/Loss - EUR | -207 | -172 | -169 | 117 | -162 | -159 | -13 | - | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
Check the financial reports for the company - Sarmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29.462 | 28.990 | 28.331 | 27.645 | 26.947 | 26.278 | 25.682 | - | - | - |
| Current Assets | 7.914 | 7.834 | 7.701 | 7.526 | 7.212 | 7.075 | 6.918 | - | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Receivables | 7.699 | 7.621 | 7.492 | 7.354 | 7.212 | 7.075 | 6.918 | - | - | - |
| Cash | 215 | 213 | 209 | 172 | 0 | 0 | 0 | - | - | - |
| Shareholders Funds | 32.545 | 32.042 | 31.331 | 30.873 | 30.113 | 29.382 | 28.718 | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | - | - | - |
| Debts | 4.831 | 4.782 | 4.701 | 4.298 | 4.046 | 3.970 | 3.882 | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "125 - 125" | |||||||||
| CAEN Financial Year |
125
|
|||||||||
Comments - Sarmed S.r.l.